Vaccinating pregnant women against RSV reduced the risk of infection in their infants by 61% compared with newborns with ...

The prescribing information for two respiratory syncytial virus (RSV) vaccines will now include a warning for the increased ...

Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

The U.S. Food and Drug Administration now requires and has approved safety labeling changes to the prescribing information ...

While presenting at the JP Morgan Healthcare Conference, Pfizer Inc. (NYSE:PFE) Albert Bourla, Chairman and CEO, said, “I ...

According to CDC researchers, cases of tularemia in the U.S. increased by nearly 60% from 2011 to 2022 compared with the ...

Expectant mothers will have access to free vaccines against respiratory syncytial virus (RSV) from next month under a major ...

“The availability of two different RSV protection methods in sufficient supply may have ... Several authors disclosed ties to pharmaceutical companies, including Pfizer, which manufactures the RSVpreF ...

Pfizer said it will 'support capacity-building initiatives, such as training healthcare professionals and advancing clinical ...

In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...

The company lost more than $3 billion in market value after cutting its forecast for 2025 revenue from its COVID-19 and RSV ...

Also Read: Pfizer And GSK’s RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder Looking at the period from 2025 to 2030, Pfizer is facing a significant loss of ...